Regulation of renal phosphate reabsorption during development: implications from a new model of growth hormone deficiency
- PMID: 2206908
- DOI: 10.1007/BF00862524
Regulation of renal phosphate reabsorption during development: implications from a new model of growth hormone deficiency
Abstract
It has been hypothesized that the high rate of renal phosphate (Pi) reabsorption in the immature animal is a consequence of the increased demand for Pi associated with the rapid rate of growth. Although growth hormone (GH) has been proposed to play a role in this process, investigations of the relationship between GH, growth and the renal Pi transport have been hampered by the lack of methods available to specifically alter circulating GH levels. This review summarizes the findings from recent studies using a newly developed peptidic antagonist to GH-releasing factor (GRF-AN) as a method of specifically inhibiting GH release. Systemic injection of GRF-AN was effective in suppressing the pulsatile release of GH, and in significantly attenuating the rate of growth, in both immature and adult rats. However, the inhibition of growth was associated with a reduction in net Pi retention only in immature rats, resulting in a doubling in the urinary excretion of Pi. GRF-AN treatment of immature rats lead to a decrease in the maximum tubular capacity to transport Pi-down to the level seen in adult rats. However, GRF-AN treatment did not alter renal Pi reabsorption in adult rats. We conclude that chronic administration of an antagonist to GRF in rats provides a new model of GH deficiency with which to study the interrelationships between growth, GH and other physiological systems. Furthermore, the findings suggest that the pulsatile release of GH, directly or indirectly, contributes to the high rate of renal Pi reabsorption in young, growing animals and may play a critical role in regulating Pi homeostasis during development.
Similar articles
-
Antagonist to GH-releasing factor inhibits growth and renal Pi reabsorption in immature rats.Am J Physiol. 1989 Jul;257(1 Pt 2):F29-34. doi: 10.1152/ajprenal.1989.257.1.F29. Am J Physiol. 1989. PMID: 2502027
-
Inhibition of pulsatile growth hormone (GH) secretion and somatic growth in immature rats with a synthetic GH-releasing factor antagonist.Endocrinology. 1989 Mar;124(3):1154-9. doi: 10.1210/endo-124-3-1154. Endocrinology. 1989. PMID: 2492921
-
Regulation of canine renal vesicle Pi transport by growth hormone and parathyroid hormone.Biochim Biophys Acta. 1980 Dec 12;603(2):322-35. doi: 10.1016/0005-2736(80)90378-8. Biochim Biophys Acta. 1980. PMID: 7459358
-
Growth factors and renal regulation of phosphate transport.Pediatr Nephrol. 1993 Dec;7(6):802-6. doi: 10.1007/BF01213364. Pediatr Nephrol. 1993. PMID: 8130113 Review.
-
[New aspect of renal phosphate reabsorption and phosphate metabolism].Clin Calcium. 2007 Oct;17(10):1485-92. Clin Calcium. 2007. PMID: 17906398 Review. Japanese.
Cited by
-
Age-associated and breed-associated variations in haematological and biochemical variables in young labrador retriever and miniature schnauzer dogs.Vet Rec Open. 2016 May 16;3(1):e000166. doi: 10.1136/vetreco-2015-000166. eCollection 2016. Vet Rec Open. 2016. PMID: 27252875 Free PMC article.
-
Recombinant growth hormone therapy for X-linked hypophosphatemia in children.Cochrane Database Syst Rev. 2021 Oct 7;10(10):CD004447. doi: 10.1002/14651858.CD004447.pub3. Cochrane Database Syst Rev. 2021. PMID: 34618915 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous